NGS Panel Development
Various Cancers & Genetic Diseases
Key Facts
About BioChain
BioChain has established itself as a critical enabler in the precision medicine ecosystem by providing an end-to-end platform from biological samples to genomic data analysis. Founded in 1996 and headquartered in Newark, California, the company serves a global clientele of researchers and diagnostic developers with high-quality reagents, biospecimens, and sequencing services. Its business model is built on a diagnostics and services platform, generating revenue through the sale of products and contract research. While privately held, BioChain occupies a strategic niche by reducing friction in the translational research pipeline, though it faces competition from larger reagent suppliers and diagnostic service providers.
View full company profile